Related News
Hospitals see no big revenue loss despite medicine markups ban: official
Online Edition
No serious revenue drops have been seen after China banned hospitals from charging a markup on drugs as part of a health corruption reform, an official said Friday.
Hospitals' profits from medicine sales have been affected but the loss is compensated by higher charges for medical service and funding from local government, said Sun Zhigang, deputy director of the National Health and Family Planning Commission, at a press conference.
The 15 percent markup on drugs sales has long been blamed for unreasonably high medical costs in China as the policy could encourage hospitals to prescribe more medicine than is necessary in order to generate revenue.
To address this, the central authority initiated a pilot which targeted price markups at public hospitals in 2012.
The pilot medical reforms will be expanded to all county-level public hospitals across the country this year, Sun said.
The official also noted the drug purchase from foreign pharmaceutical manufacturers will not be affected by the ongoing medical reform.
"Foreign drug producers have equal opportunity as domestic manufacturers when they bid for medicine supply," Sun said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
